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Open Forum Infectious Diseases
I D  C A S E S
Splenic Infarction: An  
Under-recognized Complication of 
Infectious Mononucleosis?
Yan Li,1 Ann George,1 Sami Arnaout,2 Jennifer P. Wang,2,a and George M. Abraham1,2,a
1Saint Vincent Hospital, Worcester, Massachusetts; 2University of Massachusetts Medical 
School, Worcester, Massachusetts
Splenic infarction is a rare complication of infectious mono-
nucleosis. We describe 3 cases of splenic infarction attributed 
to infectious mononucleosis that we encountered within a 
2-month period. We underscore the awareness of this poten-
tial complication of infectious mononucleosis and discuss the 
differential diagnosis of splenic infarction, including infectious 
etiologies. While symptomatic management is usually sufficient 
for infectious mononucleosis-associated splenic infarction, 
close monitoring for other complications, including splenic 
rupture, is mandated.
Keywords. Epstein-Barr virus; infectious mononucleosis; 
splenic infarction.
 
While infectious mononucleosis (IM) usually represents a 
benign clinical process, serious complications can occur. Scant 
data on the incidence of splenic infarction as a complication 
of IM exist, with the majority of the literature being individual 
case reports. We report a cluster of 3 cases of IM complicated by 
splenic infarction that we saw over a 2-month period. We aim 
to raise awareness of this potentially under-recognized clinical 
problem.
CASE 1
A 24-year-old female with Crohn’s disease, Hashimoto thyroid-
itis, and sacroiliitis presented in late summer with a 1-week his-
tory of increasingly severe left-sided abdominal pain associated 
with fever, nausea, loose stools, and fatigue. Review of systems 
was otherwise negative. She reported no sick contacts, tick bites, 
or recent travel. Family history was remarkable for thyroid dis-
ease in her mother and brother, but negative for thrombophilic 
disease. The physical exam was significant for temperature of 
38.1°C, submandibular lymphadenopathy, and abdominal ten-
derness at the left upper quadrant. Blood test results are shown 
in Table  1. Contrast computed tomography (CT) imaging of 
the abdomen and pelvis showed splenomegaly of 16.3 cm and 
multiple wedge-shaped hypodensities throughout the spleen 
consistent with infarcts (Figure 1), neither of which was pres-
ent on an imaging study 1 year before. Blood cultures and tran-
sthoracic echocardiogram were negative. Babesia polymerase 
chain reaction and Lyme antibody screen were negative. The 
patient was diagnosed with IM complicated by splenic infarc-
tion. She received supportive care and was discharged on the 
fourth hospital day with instructions to avoid contact sports. 
Approximately 2 months later, she was reassessed for Crohn’s 
disease, at which time MR enterography showed resolving sple-
nomegaly of 11.9 cm with a decrease in the size and extent of 
splenic infarcts.
CASE 2
A 20-year-old man with no significant past medical history 
presented with 5  days of neck swelling, soreness, and hives 
and 1 day of left upper quadrant abdominal pain associated 
with nausea. Review of systems was otherwise negative. He 
reported no significant sick contacts, travel, outdoor activities, 
or trauma. Family history was remarkable for stroke and deep 
vein thrombosis in his 2 maternal aunts, with no other history 
of thrombophilic diseases. Physical examination revealed a 
well-nourished male with resolving hives present on his face 
and back. The abdomen was soft with mild tenderness with-
out rebound or guarding over the left upper quadrant. The 
remainder of the exam was unremarkable. Laboratory find-
ings, including hypercoagulable workup, are shown in Table 1. 
CT scan of the abdomen and pelvis revealed hepatospleno-
megaly, multiple hypodensities suggesting splenic infarct, 
and borderline enlarged portal hepatic and periaortic lymph 
nodes. Given that no evidence of thrombophilic disease was 
found, the diagnosis of IM complicated by splenic infarction 
was made. The patient was managed conservatively with sup-
portive treatment, including intravenous fluids, analgesics, 
and antihistamines.
CASE 3
A 27-year-old man with no significant prior medical history 
presented to the emergency department with complaints of left 
upper quadrant abdominal pain for 1 week. He also had fever, 
chills, nausea, night sweats, and a sore throat. He denied recent 
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travel, tick bites, or sick contacts. Physical examination was 
remarkable for tachycardia, abdominal tenderness over the left 
upper quadrant, and mild splenomegaly. Blood work showed 
a positive heterophile antibody test, leukocytosis with 23% 
atypical lymphocytes, and transaminitis with AST 279 U/L and 
ALT 501 U/L. The patient was discharged from the emergency 
department with analgesics. He was advised to avoid contact 
sports, physical strain, hepatotoxic medications, and to return 
in several days for reevaluation. He returned 2 days later with 
worsening left upper quadrant abdominal pain and a new 
nonpruritic rash over the low back and lower extremities. He 
denied fever. A CT scan of abdomen and pelvis showed mod-
erate splenomegaly with multiple peripheral wedge-shaped 
hypodensities consistent with splenic infarcts. During the hos-
pitalization, laboratory studies and hypercoagulable workup, 
shown in Table 1, were notable only for a weakly positive anti-
cardiolipin IgM antibody, lupus anticoagulant, and slightly 
reduced protein C activity; thus his splenic infarction was con-
sidered to be a complication of IM. The patient admitted to 
occasional intravenous drug use, most recently 3 months prior 
to presentation. Following clinical improvement with symp-
tomatic treatment, he was discharged but lost to follow-up 
without completion of an infectious endocarditis workup, a 
preliminary workup having been unrevealing.
DISCUSSION
The clinical course of IM is typically characterized by nonspecific 
symptoms including fever, sore throat, and lymphadenopathy 
Table 1. Laboratory Studies
Case 1 Case 2 Case 3 Normal Range
WBC 13.3 7.4 13.7 3.9–11.0 × 1000/μL
Lymphocytes 44 1.3 6.0 0.7–4.5 × 1000/μL
Reactive/atypical lymphocytes 8 49 20 0–6%
HgB 11.9 14.7 13.3 12.5–17.0 g/dL
Platelets 236 115 323 150–450 × 1000/μL
AST 36 100 156 0–55 U/L
ALT 20 86 379 0–44 U/L
APTT 25.5 27.1 29.7 25.0–35.0 s
PT 12.1 11 11.3 9.1–12.0 s
INR 1.1 1.1 1.1 2.0–3.5
Heterophile, mononucleosis screen Positive Positive Positive Negative
Epstein-Barr virus (VCA) antibody IgG 36.8 (positive) — — <18.0
Epstein-Barr virus (VCA) antibody IgM >160.0 (positive) — — <36.0
Epstein-Barr virus nuclear antigen antibody Negative — — <18.0
Lupus anticoagulant (dilute Russell’s viper venom time) — 58 47.6 0–47 s
β-2 Glycoprotein IgM, IgG Negative Negative — <20 SU
Anticardiolipin IgM 16 (indeterminate) Negative 15 (indeterminate) <10 U/mL
Anticardiolipin IgG Negative Negative Negative <11 U/mL
Phosphatidylserine IgM 29 (equivocal) — — <25 U/mL
Phosphatidylserine IgG Negative — — <10 U/mL
Protein C activity — 86 68 73%–180%
Activated protein C resistance — 2.5 — 2.0–3.5
Free protein S — 78 — 57%–157%
Total protein S — 73 — 60%–150%
Functional protein S — — 63 63%–140%
Antithrombin III activity — 116 93 75%–135%
Factor V Leiden mutation — Negative Negative Negative
Prothrombin gene mutation — Negative Negative Negative
—, not done. Abbreviations: ALT, alanine aminotransferase; APTT, activated partial thromboplastin time; AST, aspartate aminotransferase; HgB, hemoglobin; IgA, immunoglobulin A; IgG, 
immunoglobulin G; INR, international normalized ratio; PT, prothrombin time; SU, standard units; VCA, viral capsid antigen; WBC, white blood count.
Figure 1. Contrast-enhanced abdominal computed tomography revealed spleno-
megaly with multiple wedge-shaped hypodensities throughout the spleen consist-
ent with infarcts. Representative axial and coronal images from the patient in Case 
1 are shown.
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followed by spontaneous recovery. Although splenic infarct is 
reported to be an infrequent complication of IM, quite remark-
ably, we saw 3 such cases in Worcester, Massachusetts, within 
a 2-month period. The readily available radiological tools, 
including CT scan, ultrasonography, and magnetic resonance 
imaging, contribute significantly in uncovering this potentially 
under-recognized serious complication of IM. We emphasize 
a heightened awareness for evaluating for infectious causes of 
splenic infarct, particularly given the high prevalence of IM. 
Epstein-Barr virus (EBV) represents the most common cause of 
infectious mononucleosis. A total of 23 cases of splenic infarc-
tion during acute IM due to EBV infection are reported in the 
medical literature published between 1961 and 2017 [1–4], 20 
of which are summarized by Heo et al. [1]. Our cases are sim-
ilar to these in terms of the median age of 23.5  years (range, 
7–57 years; available in 18 cases), mostly occurring in otherwise 
healthy people without underlying disease, time of symptom 
onset to diagnosis of infarction of 5  days (range, 1–25  days), 
presence of splenomegaly, and good clinical outcome [1].
Several mechanisms are proposed for the pathogenesis of 
splenic infarction during IM. First, arterial blood supply may 
be insufficient for the increased demand of the hypercellular 
spleen during acute IM, resulting in local infarct. Second, the 
presence of a transient hypercoagulable state during IM has 
been proposed. Transient elevated antiphospholipid antibod-
ies [5], lupus anticoagulant [2], and factor VIII [6] have been 
documented during the acute stage of IM when complicated 
by splenic infarction. Notably, anticardiolipin antibodies have 
been detected in 30%–62% of patients with IM with EBV, with 
the majority bearing no known clinical significance; such 
transient prothrombotic factors tend to disappear in 1–4 years 
[7]. Third, an increased level of circulating immune complexes 
due to B cell proliferation, promoting leukocyte aggregation 
and adhesiveness, has been associated with splenic infarction 
with EBV [8].
Splenic infarction complicates infections besides EBV, and 
examples are listed in Table 2. Infectious endocarditis can result 
in septic emboli to the spleen [9]. At least 11 cases of cytomeg-
alovirus-associated splenic infarction in immunocompetent 
patients have been reported, and, as with EBV, inadequate blood 
supply and transient production of antiphospholipid antibodies 
are postulated as contributors to infarct [10]. Other infections 
associated with splenic infarct include malaria and babesi-
osis, which are recognized causes of splenic disease. Forty-
four cases of malaria associated with splenic infarcts, many of 
which involved splenomegaly, were recently reviewed [11]. To 
date, 4 cases of babesiosis complicated by splenic infarct have 
been published, for which the mechanism of infarct remains 
undefined [12–14]. Malaria and babesia can be associated with 
splenic infarcts even during low parasitemia. A small number of 
cases of splenic infarction have been associated with parvovirus 
B19 infection, and very few published reports are available on 
brucella-associated splenic infarct in the absence of infectious 
endocarditis. Isolated reports have been made with murine 
typhus as well. Again, under such circumstances, the reason 
for infarct is obscure. With regards to noninfectious etiologies, 
splenic infarction occurs with myeloproliferative disorders, 
in the presence of thromboembolic or hypercoagulable states 
including malignancy and antiphospholipid syndrome, and 
with splenomegaly. Such conditions (adapted from Hunt et al. 
[15]) are listed in Table 2.
CONCLUSION
IM is a very common condition, whereas splenic infarction 
occurs relatively infrequently. Splenic infarction may mani-
fest as left upper quadrant abdominal pain during IM. When 
splenic infarct is observed on imaging studies, infectious etiol-
ogies including EBV should be considered. While symptomatic 
management is usually sufficient for IM-associated splenic 
infarction, close monitoring for other complications, including 
splenic rupture, is mandated.
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